These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Advanced non-small cell lung cancer (ANSCLC): new chemotherapy phase II studies and old faults. Tummarello D; Graziano F Lung Cancer; 1996 Nov; 15(3):375-6. PubMed ID: 8959682 [No Abstract] [Full Text] [Related]
11. Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure? Socinski MA J Clin Oncol; 2009 Jul; 27(20):3268-70. PubMed ID: 19470913 [No Abstract] [Full Text] [Related]
12. Duration of chemotherapy for metastatic non-small-cell lung cancer: more may be better after all. Schiller JH; Ramalingam SS J Clin Oncol; 2009 Jul; 27(20):3265-7. PubMed ID: 19470911 [No Abstract] [Full Text] [Related]
18. [The status of chemotherapy in non-small-cell bronchial carcinoma]. Drings P; Manegold C Strahlenther Onkol; 1994 Sep; 170(9):495-506. PubMed ID: 7940122 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for advanced NSCLC: any light at the end of the tunnel? Jassem J Lancet Oncol; 2007 Jun; 8(6):461-3. PubMed ID: 17540302 [No Abstract] [Full Text] [Related]
20. [Current approaches to the use of radiotherapy in patients with non-small-cell lung cancer]. Goldobenko GV; Kanaev SV Vopr Onkol; 1998; 44(5):623-8. PubMed ID: 9884730 [No Abstract] [Full Text] [Related] [Next] [New Search]